NxStage Medical Inc., a Lawrence-based medical products company, is part of a team that has won a federal contract to develop a portable medical device for treating soldiers with sepsis.
The contract, from the US Defense Advanced Research Projects Agency (or DARPA), could be worth up to $22.83 million. Other members of the team are Battelle and Aethlon Medical.
The device would be somewhat similar to a dialysis machine. It would remove blood from the body and filter out harmful agents that can cause sepsis before returning “clean” blood to the body. The hope is that the device would also eventually have civilian applications.
“NxStage is pleased to be chosen as part of this team based upon our recognized expertise in developing and commercializing innovative, portable technology for the purification of blood, which includes use of the System One in the military environment,” NxStage Medical chief executive Jeffrey H. Burbank said in a statement. “We are confident that our leadership in device design will lead to a good outcome for this important DARPA project, ultimately benefitting military personnel and civilians alike.”
NxStage Medical is the creator of the NxStage System One, a portable home hemodialysis machine used in the treatment of kidney failure.